Uses of Nanoparticles for Central Nervous System Imaging and Therapy

References

1. ↵
   Leary SP, Liu CY, Apuzzo MLJ. Toward the emergence of nanoneurosurgery. Part III. Nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery. Neurosurgery 2006;58:1009–26

   CrossRefPubMedWeb of Science
2. ↵
   Gilmore JL, Yi X, Quan L, et al. Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 2008;3:83–94. Epub 2008 Jan 22

   CrossRefPubMed
3. ↵
   Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5:161–71

   CrossRefPubMedWeb of Science
4. ↵
   Enochs WS, Harsh G, Hochberg F, et al. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999;9:228–32

   CrossRefPubMedWeb of Science
5. ↵
   Varallyay CG, Muldoon LL, Gahramanov S, et al. Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model. J Cereb Blood Flow Metab 2009;29:853–60. Epub 2009 Jan 14

   CrossRefPubMedWeb of Science
6. ↵
   Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319–31

   CrossRefPubMedWeb of Science
7. ↵
   Sun C, Veiseh O, Gunn J, et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008;4:372–79

   CrossRefPubMed
8. ↵
   Neuwelt EA, Várallyay P, Bagó AG, et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 2004;30:456–71

   CrossRefPubMedWeb of Science
9. ↵
   Loo C, Lin A, Hirsch L, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 2004;3:33–40

   Abstract/FREE Full Text
10. ↵
    Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008;269:57–66. Epub 2008 Jun 9

    CrossRefPubMed
11. ↵
    Xing Y, Chaudry Q, Shen C, et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc 2007;2:1152–65

    CrossRefPubMedWeb of Science
12. ↵
    Pathak S, Cao E, Davidson MC, et al. Quantum dot applications to neuroscience: new tools for probing neurons and glia. J Neurosci 2006;26:1893–95

    FREE Full Text
13. ↵
    Ruiz MA, Clares B, Morales ME, et al. Vesicular lipidic systems, liposomes, PLO, and liposomes-PLO: characterization by electronic transmission microscopy. Drug Dev Ind Pharm 2008;34:1269–76

    CrossRefPubMed
14. ↵
    Ahmed F, Discher DE. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release 2004;96:37–53

    CrossRefPubMedWeb of Science
15. ↵
    Poletti P, Bettini AC, Caremoli ER, et al. Liposomal-encapsulated doxorubicin (Myocet; D-99) and vinorelbine in previously treated metastatic breast cancer patients: a feasibility study. Tumori 2008;94:686–90

    PubMed
16. ↵
    Di Paolo D, Pastorino F, Brignole C, et al. Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment. Tumori 2008;94:246–53

    PubMed
17. ↵
    Liu L, Venkatraman SS, Yang YY, et al. Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers 2008;90:617–23

    CrossRefPubMed
18. ↵
    Calvo P, Gouritin B, Villarroya H, et al. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur J Neurosci 2002;15:1317–26

    CrossRefPubMed
19. ↵
    Silva GA. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surg Neurol 2007;67:113–16

    CrossRefPubMed
20. ↵
    Reimold I, Domke D, Bender J, et al Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm 2008;70:627–32

    CrossRefPubMed
21. ↵
    Gulyaev AE, Gelperina SE, Skidan IN, et al. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 1999;16:1564–69

    CrossRefPubMedWeb of Science
22. ↵
    Olbrich C, Gessner A, Kayser O, et al. Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J Drug Target 2002;10:387–96

    CrossRefPubMed
23. ↵
    Alyaudtin RN, Reichel A, Lobenberg R, et al. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target 2001;9:209–21

    PubMed
24. ↵
    Steiniger SC, Kreuter J, Khalansky AS, et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004;109:759–67

    CrossRefPubMedWeb of Science
25. ↵
    Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22:969–76

    CrossRefPubMedWeb of Science
26. ↵
    Gelperina S, Kisich K, Iseman MD, et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487–90

    CrossRefPubMedWeb of Science
27. ↵
    Vyas SP, Gupta S. Optimizing efficacy of amphotericin B through nanomodification. Int J Nanomedicine 2006;1:417–32

    CrossRefPubMed
28. ↵
    Wieder ME, Hone DC, Cook MJ, et al. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a “Trojan horse.” Photochem Photobiol Sci 2006;5:727–34. Epub 2006 Jun 21

    CrossRefPubMed
29. ↵
    Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000;60:4440–45

    Abstract/FREE Full Text
30. ↵
    Walker GF, Fella C, Pelisek J, et al. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 2005;11:418–25

    PubMed
31. ↵
    Gu J, Cheng WP, Liu J, et al. pH-triggered reversible “stealth” polycationic micelles. Biomacromolecules 2008;9:255–62

    CrossRefPubMed
32. ↵
    Lee JH, Jun YW, Yeon SI, et al. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed Engl 2006;45:8160–62

    CrossRefPubMed
33. ↵
    Vu TQ, Maddipati R, Blute TA, et al. Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano Lett 2006;5:603–07

    CrossRef
34. ↵
    Dahan M, Levi S, Luccardini C, et al. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003;302:442–45

    Abstract/FREE Full Text
35. ↵
    Yin JJ, Lao F, Fu PP, et al. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 2009;30:611–21

    CrossRefPubMedWeb of Science
36. ↵
    Dugan LL, Lovett EG, Quick KL, et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 2001;7:243–46

    CrossRefPubMedWeb of Science
37. ↵
    Jeffery ND, McBain SC, Dobson J, et al. Uptake of systemically administered magnetic nanoparticles (MNPs) in areas of experimental spinal cord injury (SCI). J Tissue Eng Regen Med 2009;3:153–57

    CrossRefPubMed
38. ↵
    Delcroix GJ, Jacquart M, Lemaire L, et al. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res 2009;1255:18–31. Epub 2008 Dec 11

    CrossRefPubMed
39. ↵
    Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005;352:2069–81

    CrossRefPubMedWeb of Science
40. ↵
    Rice HE, Hsu EW, Sheng H, et al. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. AJR Am J Roentgenol 2007;188:1101–08

    CrossRefPubMed
41. ↵
    Jendelová P, Herynek V, Urdzíková L, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004;76:232–43

    CrossRefPubMedWeb of Science
42. ↵
    Silva GA. Neuroscience nanotechnology: progress, opportunities and challenges. Nat Rev Neurosci 2006;7:65–74

    CrossRefPubMedWeb of Science
43. ↵
    Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004;303:1352–55

    Abstract/FREE Full Text
44. ↵
    Sun EY, Weissleder R, Josephson L. Continuous analyte sensing with magnetic nanoswitches. Small 2006;2:1144–47

    CrossRefPubMed
45. ↵
    Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2007;18:4–10

    CrossRefPubMedWeb of Science
46. ↵
    Winter PM, Caruthers SD, Kassner A, et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel α ν β 3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging. Cancer Res 2003;63:5838–43

    Abstract/FREE Full Text
47. ↵
    Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006;12:6677–86

    Abstract/FREE Full Text